Skip to content

Sana Biotechnology SANA Change in Other Assets

Change in Other Assets at other companies

CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$247K-61.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$662K+138%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$12.97M+6,050%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.47M-54.9%
Precigen logo
PrecigenPGEN
$562K+1,322%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$31.86M+65,122%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's change in other assets?
Sana Biotechnology (SANA) reported change in other assets of -$1.63M in Q1 2026.
How has Sana Biotechnology's change in other assets changed year-over-year?
Sana Biotechnology's change in other assets decreased by 19.0% year-over-year, from -$1.37M to -$1.63M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.